共 50 条
- [41] NORMALIZATION OF HEMATOCRIT IN PATIENTS WITH END-STAGE RENAL-DISEASE ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS - THE ROLE OF ERYTHROPOIETIN [J]. AMERICAN JOURNAL OF MEDICINE, 1982, 72 (01): : 53 - 57
- [44] GROWTH IN CHILDREN WITH END-STAGE RENAL-DISEASE TREATED WITH CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS FOR AT LEAST ONE YEAR [J]. PERITONEAL DIALYSIS BULLETIN, 1982, 2 (04): : 159 - 161
- [45] MULTICENTER STUDY OF LIPOPROTEIN(A) AND APOLIPOPROTEIN(A) PHENOTYPES IN PATIENTS WITH END-STAGE RENAL-DISEASE TREATED BY HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (01): : 110 - 120
- [46] PHARMACOKINETICS OF VANCOMYCIN FOLLOWING INTRAABDOMINAL ADMINISTRATION IN PATIENTS WITH CHRONIC RENAL-FAILURE UNDER CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD) [J]. PATHOLOGIE BIOLOGIE, 1985, 33 (5BIS): : 542 - 544
- [47] END-STAGE RENAL-FAILURE DUE TO MULTIPLE-MYELOMA - POOR SURVIVAL ON PERITONEAL-DIALYSIS [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1988, 11 (01): : 39 - 42
- [48] CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD) - AN ESTABLISHED TREATMENT FOR ENDSTAGE RENAL-FAILURE [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1983, 13 (05): : 489 - 496